Prescribing Patterns of Antihypertensives for Treatment-Naïve Patients in South Korea: From Korean NHISS Claim Data

• Published in: International journal of hypertension 2019, Vol.2019 (2019), p.1-10
• Main Authors: Kwon, Yong-Chol, Kim, Yul-Hee, Park, Sang-hyun, Han, Kyung Do, Kim, Shinhye, Shin, Dong Wook, Kim, Sang Hyuck, Jeon, Shin-Ae
• Format: Article
• Language: English
• Subjects: Age; Analysis; Antihypertensives; Blood pressure; Calcium channels; Cardiovascular disease; Chronic illnesses; Comorbidity; Diabetes; Drug dosages; Drug therapy, Combination; Drugs; Enzyme inhibitors; Enzymes; Health insurance; Health insurance industry; Heart failure; Hospitals; Hypertension; Indapamide; Kidney diseases; Medical research; Medical screening; Medicine, Experimental; Mortality; National health insurance; Online databases; Patient compliance; Patients; Population; Prescribing; Prescription drugs; Prescription writing; Preventive medicine; Systematic review; Trends
• ISSN: 2090-0384; 2090-0392; 2090-0392
• DOI: 10.1155/2019/4735876

Background. Several factors influence the choice of antihypertensive drugs. To facilitate the rational use of drugs it is important to assess their prescription patterns over time. This study aims to evaluate doctors’ prescribing patterns of antihypertensive drugs for drug-naïve patients in South Korea. Methods. The claims data of the Korean National Health Insurance Research Database from 1 January 2011 to 31 December 2015 were analyzed. The data virtually cover the entire South Korean population. Antihypertensive drugs were further subdivided into angiotensin receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACEis), calcium channel blockers (CCBs), beta-blockers (BBs), and thiazide diuretics. The prescription pattern of antihypertensive drugs and associated factors were assessed according to the patients’ characteristics, including associated comorbidities. Results. A total of 2,919,162 subjects had started taking antihypertension medications during the study period. ARB was the most frequently prescribed drug (51.6%) followed by CCB (45.0%), BB (18.5%), diuretics (17.0%), and ACEi (11.7%). Most patients were prescribed with monotherapy (66.7%) rather than combination therapy (33.3%), and CCB was the most frequently prescribed monotherapy drug (25.7%). For combination therapy, ARB + CCB was the most frequently prescribed combination, and the prescription frequency was found to be increasing. In patients prescribed with combination therapy, most had been prescribed single-pill fixed-dose combination. Conclusion. We identified the physicians’ prescription patterns of antihypertensive drugs for treatment-naïve patients. The findings of this study can lead to a rational, evidence-based, and cost-effective improvement of prescription patterns in newly diagnosed hypertensive patients.